Pricing Log in Create free account

Kura Oncology, Inc. (KURA) vs Obsidian Therapeutics, Inc (OBX)

Kura Oncology, Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Kura Oncology, Inc. and Obsidian Therapeutics, Inc are of similar size ($604.9M and $593.0M). Across the 5 metrics below, Obsidian Therapeutics, Inc leads on 4 and Kura Oncology, Inc. on 1.

Valuation

Metric KURA OBX Biotechnology median
P/E n/m — 10.60
P/S 8.31 n/m 9.40
P/B 13.25 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.71 n/m 9.02
Earnings yield (46.68%) — (32.88%)
Free cash flow yield (18.30%) 0.00% (23.13%)

Profitability

Metric KURA OBX Biotechnology median
Gross margin 99.35% — 68.51%
Operating margin (411.90%) — 0.00%
Net margin (384.30%) — 0.00%
Free cash flow margin (152.06%) — 0.00%
Return on equity (167.71%) — (51.96%)
Return on assets (46.73%) — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KURA OBX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (57.43%) (11.60%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KURA OBX Biotechnology median
Debt to equity 0.20 0.00 0.00
Current ratio 4.73 4.21 4.97
Net debt to EBITDA 2.11 0.77 1.01

Dividend

Metric KURA OBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KURA OBX Biotechnology median
Market cap 604.93m 593.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack